文献速递头颈外科

头颈鳞癌同步放化疗中皮肤剂量分布预测重度放射性皮炎

Analysis of skin dose distribution for the prediction of severe radiation dermatitis in head and neck squamous cell carcinoma patients treated with concurrent chemo-radiotherapy.
PubMed 文献 · Head Neck · 2019-11-04

本研究纳入90例接受IMRT同步顺铂或西妥昔单抗治疗的头颈鳞癌患者,分析皮肤剂量分布与G3/G4放射性皮炎的相关性。G3/G4放射性皮炎发生率为41.1%,西妥昔单抗组为50%,顺铂组为36.6%。多因素分析仅PS≥1和放疗结束时体重下降>10 kg保持显著,皮肤环2 mm V50为19.9 cc和V60为5.8 cc时预测准确性最佳,AUC均为0.61。

要点

  • G3/G4放射性皮炎发生率为41.1%,西妥昔单抗组50%,顺铂组36.6%。
  • PS≥1和放疗结束时体重下降>10 kg是独立显著因素。
  • 皮肤环2 mm V50 19.9 cc和V60 5.8 cc预测重度放射性皮炎AUC均为0.61。

核心结论

  • 结合临床因素,皮肤表面下2 mm环状结构的剂量分布可能有助于预测重度放射性皮炎的发生。

研究设计与样本

  • 频率匹配队列分析,纳入90例接受IMRT同步顺铂或西妥昔单抗治疗的头颈鳞癌患者,采用Poisson回归模型计算风险比。

主要发现

  • 90例患者中G3/G4放射性皮炎发生率为41.1%,西妥昔单抗组为50%,顺铂组为36.6%。
  • 多因素分析中仅PS≥1和放疗结束时体重下降>10 kg保持显著。
  • 皮肤环2 mm V50为19.9 cc和V60为5.8 cc时预测准确性最佳,AUC均为0.61。

关键数值与推荐

  • G3/G4放射性皮炎发生率41.1%(90例患者)。
  • 西妥昔单抗组G3/G4放射性皮炎发生率50%,顺铂组36.6%。
  • 皮肤环2 mm V50 19.9 cc和V60 5.8 cc预测重度放射性皮炎的AUC均为0.61。

临床怎么用

  • 在IMRT计划评估中可关注皮肤环2 mm的V50和V60剂量体积参数,结合PS和体重变化识别重度放射性皮炎高危患者。

局限性

  • 预测模型AUC仅为0.61,区分度有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We investigated whether the pattern of intensity-modulated radiotherapy (IMRT) dose distribution to the skin can be correlated with the development of G3/G4 radiation dermatitis (RD). METHODS: A frequency-matched cohort analysis was perfomed on patients treated with IMRT and concurrent cisplatin or cetuximab. Risk ratios were obtained by fitting Poisson regression models. RESULTS: The incidence of G3/G4 RD was 41.1% in 90 patients included (50% vs 36.6% in the cetuximab and cisplatin cohorts, respectively). In multivariate analysis, PS ≥ 1 and weight loss at RT completion >10 kg were the only factors that retained significance. The best dosimetric predictive accuracy was provided by 19.9 cc and 5.8 cc of skin ring 2 mm V50 and V60, respectively (AUC: 0.61 for both). CONCLUSION: Along with clinical factors, the pattern of dose distribution to a ring structure localized 2 mm below the patient's surface may help predict the development of severe RD.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Bonomo P, Talamonti C, Desideri I, et al. Analysis of skin dose distribution for the prediction of severe radiation dermatitis in head and neck squamous cell carcinoma patients treated with concurrent chemo-radiotherapy. Head Neck. 2019. PMID: 31682308. doi:10.1002/hed.25997

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。